IGF-1 LR3 Research Peptide | Biovantage Labs

IGF-1 LR3 Research Peptide | Biovantage Labs

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a recombinant analogue of IGF-1 with an N-terminal extension and Arg3 substitution, studied for reduced IGF binding protein affinity and extended half-life in cell proliferation, differentiation, and anabolic signalling research models. Biovantage Labs supplies IGF-1 LR3 at 99+% purity, HPLC/MS verified. Domestically fulfilled from Canada. Not for human consumption.

$80.00

Description

IGF-1 LR3 Biovantage Labs Research Peptide

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a recombinant analogue of IGF-1 with an N-terminal extension and Arg3 substitution, studied for reduced IGF binding protein affinity and extended half-life in cell proliferation, differentiation, and anabolic signalling research models. Biovantage Labs supplies IGF-1 LR3 at 99+% purity, HPLC/MS verified. Domestically fulfilled from Canada. Not for human consumption. Biovantage Labs provides this compound at 99+% purity, confirmed by batch-specific HPLC and Mass Spectrometry analysis, as a lyophilized compound for use in controlled laboratory settings.

Molecular Profile and Chemical Specifications

Specification Detail
Molecular Formula C400H625N111O115S9
Molecular Weight 9,111 Da
Modifications 13-AA N-terminal extension; Arg3 substitution (reduces IGFBP-3 affinity ~500-fold)
Purity ≥99+% (HPLC/MS verified)
Physical Form Lyophilized white powder
CAS Number 946870-92-4

 

Primary Research Mechanisms

IGF-1 Receptor Activation and PI3K-Akt-mTOR Signalling

IGF-1 LR3 binds the IGF-1 receptor (IGF1R) with affinity comparable to native IGF-1, activating the PI3K-Akt-mTOR cascade. Research examining this pathway investigates downstream regulation of protein synthesis, cell cycle progression, and anti-apoptotic signalling.

IGF-1 LR3 is frequently used as a direct receptor-level tool in research protocols that also examine HGH (Human Growth Hormone), allowing investigators to distinguish between GH-mediated hepatic IGF-1 production and direct IGF-1 receptor activation as separate variables in anabolic signalling research.

IGFBP Displacement and Extended Bioavailability Research

The Arg3 substitution dramatically reduces IGF-1 LR3’s affinity for IGF binding proteins (IGFBPs), which normally sequester approximately 95% of circulating IGF-1. Research using LR3 versus native IGF-1 allows investigation of free versus bound IGF-1 contributions to receptor signalling in cell culture and animal models.

Skeletal Muscle and Satellite Cell Research

IGF-1 LR3’s extended bioavailability makes it a preferred research tool for studying IGF-1 receptor-mediated satellite cell activation and myoblast proliferation in skeletal muscle models, where native IGF-1’s rapid IGFBP sequestration limits experimental control.

Skeletal muscle hypertrophy research examining the IGF-1 axis is often designed alongside myostatin pathway inhibition studies using Follistatin-344, allowing comparative investigation of anabolic signalling through IGF-1R versus TGF-beta pathway blockade.

Reconstitution Protocol

  • Reconstitute using sterile bacteriostatic water or 0.9% sodium chloride solution
  • Introduce diluent slowly along the interior vial wall do not inject directly onto the lyophilized cake
  • Swirl gently until fully dissolved do not shake or vortex
  • Allow the vial to equilibrate to room temperature before opening to prevent condensation

Storage and Stability

Storage Condition State Estimated Stability
-20°C to -80°C Lyophilized 24+ months
2°C to 8°C Lyophilized 12 months
Room temperature (20°C) Lyophilized 3 months
2°C to 8°C Reconstituted 7 to 14 days

 

Store in a desiccated environment away from UV exposure. Avoid repeated freeze-thaw cycles, which degrade peptide chain integrity over time.

IGF-1 LR3 Research FAQ

Q: How does the half-life of IGF-1 LR3 compare to native IGF-1 in research models?

A: Native IGF-1 has a half-life of minutes when free and hours when IGFBP-bound. IGF-1 LR3’s reduced IGFBP affinity results in a plasma half-life of approximately 20 to 30 hours in rodent models a significant extension that allows sustained receptor engagement in longer experimental protocols.

Q: Is IGF-1 LR3 for human use?

A: No. IGF-1 LR3 supplied by Biovantage Labs is strictly for laboratory research purposes. It is not approved for human consumption, veterinary use, or clinical application.

Q: What purity standard does Biovantage Labs apply?

A: Every batch is verified at 99+% purity using HPLC to confirm compound concentration and Mass Spectrometry to confirm molecular identity. Batch-specific COA documentation is available upon request.

Q: Where does Biovantage Labs ship from?

A: All Biovantage Labs products are fulfilled domestically from within Canada, eliminating customs clearance risk and reducing transit time compared to international suppliers.

 

Reviews

There are no reviews yet.

Be the first to review “IGF-1 LR3 Research Peptide | Biovantage Labs”

Your email address will not be published. Required fields are marked *

Related Products

High Quality Research Peptides You Can Trust

Explore premium-grade peptides for scientific research, purity tested, lab certified, and shipped discreetly.